Cyndeo Wealth Partners LLC Has $4.30 Million Stock Holdings in HCA Healthcare, Inc. $HCA

Cyndeo Wealth Partners LLC lessened its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 58.7% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 10,099 shares of the company’s stock after selling 14,376 shares during the period. Cyndeo Wealth Partners LLC’s holdings in HCA Healthcare were worth $4,304,000 at the end of the most recent reporting period.

A number of other large investors have also made changes to their positions in HCA. Brighton Jones LLC purchased a new position in HCA Healthcare during the 4th quarter worth approximately $1,021,000. T. Rowe Price Investment Management Inc. raised its position in HCA Healthcare by 13.1% during the first quarter. T. Rowe Price Investment Management Inc. now owns 2,546 shares of the company’s stock valued at $880,000 after buying an additional 295 shares during the period. CW Advisors LLC grew its stake in HCA Healthcare by 22.9% during the 1st quarter. CW Advisors LLC now owns 1,277 shares of the company’s stock valued at $441,000 after acquiring an additional 238 shares in the last quarter. Norinchukin Bank The lifted its position in shares of HCA Healthcare by 10.7% in the first quarter. Norinchukin Bank The now owns 7,966 shares of the company’s stock worth $2,753,000 after purchasing an additional 770 shares in the last quarter. Finally, Ameriprise Financial Inc. increased its stake in HCA Healthcare by 10.2% in the 1st quarter. Ameriprise Financial Inc. now owns 483,564 shares of the company’s stock valued at $167,094,000 after buying an additional 44,884 shares during the period. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare Trading Up 1.3%

Shares of HCA Healthcare stock opened at $472.69 on Friday. The stock has a market capitalization of $107.87 billion, a price-to-earnings ratio of 18.27, a PEG ratio of 1.40 and a beta of 1.36. HCA Healthcare, Inc. has a 1-year low of $289.98 and a 1-year high of $520.00. The firm has a fifty day simple moving average of $470.12 and a 200-day simple moving average of $417.03.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings results on Friday, October 24th. The company reported $6.96 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.64 by $1.32. HCA Healthcare had a net margin of 8.53% and a negative return on equity of 792.25%. The company had revenue of $19.16 billion during the quarter, compared to analysts’ expectations of $18.55 billion. During the same period in the prior year, the company earned $4.90 earnings per share. The business’s quarterly revenue was up 9.6% compared to the same quarter last year. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. As a group, research analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, December 29th. Stockholders of record on Monday, December 15th will be given a $0.72 dividend. This represents a $2.88 annualized dividend and a dividend yield of 0.6%. The ex-dividend date of this dividend is Monday, December 15th. HCA Healthcare’s dividend payout ratio is currently 11.13%.

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on the stock. Jefferies Financial Group boosted their price target on shares of HCA Healthcare from $485.00 to $525.00 and gave the company a “buy” rating in a report on Tuesday, October 28th. Cowen reaffirmed a “buy” rating on shares of HCA Healthcare in a research report on Monday, October 27th. Zacks Research cut HCA Healthcare from a “strong-buy” rating to a “hold” rating in a research note on Thursday, November 27th. Royal Bank Of Canada lifted their target price on shares of HCA Healthcare from $482.00 to $525.00 and gave the company an “outperform” rating in a research note on Friday. Finally, UBS Group raised their price target on shares of HCA Healthcare from $495.00 to $525.00 and gave the company a “buy” rating in a report on Monday, October 27th. Fourteen research analysts have rated the stock with a Buy rating, nine have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $479.00.

Insider Transactions at HCA Healthcare

In related news, EVP Michael R. Mcalevey sold 3,892 shares of the company’s stock in a transaction on Wednesday, November 5th. The shares were sold at an average price of $473.79, for a total transaction of $1,843,990.68. Following the completion of the transaction, the executive vice president directly owned 3,487 shares in the company, valued at $1,652,105.73. This represents a 52.74% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Company insiders own 1.30% of the company’s stock.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.